Physician
East Coast Pathology of Florida, PA
East Coast Pathology of Florida, PA was paid $1.24M by Medicaid between Jan 2018 and Dec 2024, across 130 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 22% of everything it billed.
33Billing provider infoEAST COAST PATHOLOGY OF FLORIDA, PA
ORMOND BEACH, FL 32174
ORMOND BEACH, FL 32174
33aNPI1154601912assigned 08/25/2011
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.24M
24GClaims820,931
24DCodes billed130
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#16 of 207
Median peer was paid$39K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,670 | $45K | |
| 2019 | 100,143 | $170K | |
| 2020 | 96,428 | $220K | |
| 2021 | 129,419 | $258K | |
| 2022 | 156,886 | $154K | |
| 2023 | 197,360 | $247K | |
| 2024incomplete | 121,025 | $146K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 22% | 9,402 | 7,380 | $274K |
| 80053 | Comprehensive metabolic panel | 9.4% | 88,424 | 55,344 | $117K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.3% | 112,630 | 61,043 | $78K |
| 84484 | 4.9% | 25,635 | 17,849 | $61K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.6% | 11,222 | 6,668 | $57K |
| 82947 | 4.6% | 49,088 | 14,771 | $57K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.1% | 5,085 | 4,198 | $50K |
| 87040 | 3.6% | 16,967 | 11,925 | $45K | |
| 81025 | 2.9% | 19,866 | 17,280 | $36K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.5% | 5,247 | 4,412 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 37,139 | 14,537 | $28K |
| 83605 | 2.3% | 17,672 | 11,862 | $28K |
118 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.0% | 18,983 | $24K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 1,365 | $23K |
| 81001 | 1.8% | 39,665 | $22K | |
| 83735 | 1.7% | 34,806 | $21K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.4% | 4,176 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 4,827 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 4,824 | $14K |
| 83690 | 1.1% | 23,811 | $14K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.0% | 6,988 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,691 | $12K |
| 87077 | <1% | 8,509 | $12K | |
| 85027 | <1% | 19,703 | $11K | |
| 82435 | <1% | 484 | $10K | |
| 84703 | <1% | 14,728 | $9K | |
| 85730 | <1% | 19,077 | $9K | |
| 81003 | <1% | 17,852 | $9K | |
| 84702 | <1% | 5,908 | $9K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 2,538 | $8K |
| 87070 | <1% | 6,047 | $7K | |
| 82565 | <1% | 2,013 | $7K | |
| 85610 | <1% | 23,492 | $7K | |
| 80061 | Lipid panel | <1% | 4,864 | $6K |
| 87186 | <1% | 6,569 | $6K | |
| 82803 | <1% | 2,310 | $5K | |
| 86850 | <1% | 7,552 | $5K | |
| 86900 | <1% | 15,450 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,913 | $5K |
| 84100 | <1% | 12,354 | $4K | |
| 86140 | <1% | 6,370 | $4K | |
| 86901 | <1% | 15,425 | $3K | |
| 87081 | <1% | 3,056 | $3K | |
| 85379 | <1% | 4,247 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 757 | $3K |
| 84145 | <1% | 6,186 | $3K | |
| 87420 | <1% | 2,397 | $3K | |
| 0225U | <1% | 698 | $3K | |
| 82728 | <1% | 1,372 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 489 | $2K |
| 82550 | <1% | 3,174 | $2K | |
| 84466 | <1% | 1,055 | $2K | |
| 88342 | <1% | 365 | $2K | |
| 82607 | <1% | 894 | $2K | |
| 83516 | <1% | 282 | $2K | |
| 86803 | <1% | 854 | $2K | |
| 84439 | <1% | 1,645 | $2K | |
| 86880 | <1% | 5,140 | $1K | |
| 83880 | <1% | 7,067 | $1K | |
| 85007 | <1% | 3,411 | $1K | |
| 87205 | <1% | 2,901 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 97 | $1K |
| 85652 | <1% | 2,119 | $1K | |
| 87340 | <1% | 896 | $1K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 257 | $814.98 |
| 87210 | <1% | 1,977 | $811.20 | |
| 87807 | <1% | 580 | $783.68 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 186 | $717.38 |
| 82247 | <1% | 2,918 | $715.10 | |
| 83540 | <1% | 1,104 | $713.41 | |
| 84132 | <1% | 1,912 | $705.01 | |
| 88304 | <1% | 110 | $685.55 | |
| 85014 | <1% | 3,758 | $681.87 | |
| 86762 | <1% | 393 | $680.42 | |
| 82248 | <1% | 2,247 | $674.14 | |
| 80202 | <1% | 550 | $671.13 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 395 | $653.00 |
| 88307 | <1% | 31 | $586.55 | |
| 80047 | <1% | 447 | $514.69 | |
| 80349 | <1% | 281 | $506.87 | |
| 86787 | <1% | 244 | $447.18 | |
| 82570 | <1% | 707 | $418.55 | |
| 86592 | <1% | 723 | $382.01 | |
| 85018 | <1% | 2,550 | $342.58 | |
| 80050 | General health panel | <1% | 141 | $334.33 |
| 82805 | <1% | 82 | $328.67 | |
| 82746 | <1% | 222 | $321.65 | |
| 82375 | <1% | 260 | $230.53 | |
| 87270 | <1% | 298 | $208.38 | |
| 87641 | <1% | 62 | $200.44 | |
| 80076 | <1% | 136 | $199.55 | |
| 87640 | <1% | 27 | $182.55 | |
| 82951 | <1% | 77 | $161.63 | |
| 82140 | <1% | 177 | $153.29 | |
| 84520 | <1% | 582 | $148.53 | |
| 83550 | <1% | 200 | $135.81 | |
| 87449 | <1% | 96 | $122.55 | |
| 82010 | <1% | 257 | $101.05 | |
| 83615 | <1% | 295 | $97.18 | |
| 84156 | <1% | 267 | $97.04 | |
| 84030 | <1% | 421 | $81.99 | |
| 83050 | <1% | 266 | $77.47 | |
| 87507 | <1% | 32 | $75.42 | |
| 80074 | <1% | 12 | $56.87 | |
| 84295 | <1% | 506 | $48.75 | |
| 85045 | <1% | 94 | $46.96 | |
| 80306 | <1% | 101 | $46.04 | |
| 85008 | <1% | 192 | $43.28 | |
| 82553 | <1% | 61 | $30.87 | |
| 80051 | <1% | 42 | $30.45 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 30 | $30.45 |
| 80069 | <1% | 37 | $22.92 | |
| 83655 | <1% | 12 | $20.40 | |
| 82330 | <1% | 14 | $19.13 | |
| 82274 | <1% | 76 | $16.68 | |
| 87341 | <1% | 17 | $12.32 | |
| 84460 | <1% | 15 | $9.42 | |
| 84478 | <1% | 56 | $8.98 | |
| 82077 | <1% | 2,861 | $6.95 | |
| 84550 | <1% | 16 | $6.26 | |
| 85384 | <1% | 15 | $3.90 | |
| 87806 | <1% | 190 | $3.80 | |
| 84300 | <1% | 17 | $3.66 | |
| 82272 | <1% | 12 | $1.56 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 34 | $0.00 |
| 80305 | 0% | 104 | $0.00 | |
| 80179 | 0% | 126 | $0.00 | |
| 86923 | 0% | 114 | $0.00 | |
| 80143 | 0% | 102 | $0.00 | |
| 87481 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAROCHO, JAMES (PRESIDENT)